key: cord-0078192-ylcnqp64
authors: Olson, Philip; Dudley, Anne G.; Rowe, Courtney K.
title: Contemporary Management of Urinary Tract Infections in Children
date: 2022-05-16
journal: Curr Treat Options Peds
DOI: 10.1007/s40746-022-00242-1
sha: c202d1b73ec5846bab4065e54565c0b815960c45
doc_id: 78192
cord_uid: ylcnqp64

PURPOSE OF REVIEW: Urinary tract infection (UTI) in children is a major source of office visits and healthcare expenditure. Research into the diagnosis, treatment, and prophylaxis of UTI has evolved over the past 10 years. The development of new imaging techniques and UTI screening tools has improved our diagnostic accuracy tremendously. Identifying who to treat is imperative as the increase in multi-drug-resistant organisms has emphasized the need for antibiotic stewardship. This review covers the contemporary management of children with UTI and the data-driven paradigm shifts that have been implemented into clinical practice. RECENT FINDINGS: With recent data illustrating the self-limiting nature and low prevalence of clinically significant vesicoureteral reflux (VUR), investigational imaging in children has become increasingly less frequent. Contrast-enhanced voiding urosonogram (CEVUS) has emerged as a useful diagnostic tool, as it can provide accurate detection of VUR without the need of radiation. The urinary and intestinal microbiomes are being investigated as potential therapeutic drug targets, as children with recurrent UTIs have significant alterations in bacterial proliferation. Use of adjunctive corticosteroids in children with pyelonephritis may decrease the risk of renal scarring and progressive renal insufficiency. The development of a vaccine against an antigen present on Escherichia coli may change the way we treat children with recurrent UTIs. SUMMARY: The American Academy of Pediatrics defines a UTI as the presence of at least 50,000 CFU/mL of a single uropathogen obtained by bladder catheterization with a dipstick urinalysis positive for leukocyte esterase (LE) or WBC present on urine microscopy. UTIs are more common in females, with uncircumcised males having the highest risk in the first year of life. E. coli is the most frequently cultured organism in UTI diagnoses and multi-drug-resistant strains are becoming more common. Diagnosis should be confirmed with an uncontaminated urine specimen, obtained from mid-stream collection, bladder catheterization, or suprapubic aspiration. Patients meeting criteria for imaging should undergo a renal and bladder ultrasound, with further investigational imaging based on results of ultrasound or clinical history. Continuous antibiotic prophylaxis is controversial; however, evidence shows patients with high-grade VUR and bladder and bowel dysfunction retain the most benefit. Open surgical repair of reflux is the gold standard for patients who fail medical management with endoscopic approaches available for select populations.

Urinary tract infection (UTI) is one of the most common diagnoses affecting children and infants, accounting for 0.7% of physician office visits and 5-14% of emergency room visits per year [65] . Over the last 10 years, there has been a shift in the management of UTI, particularly regarding diagnosis and antibiotic prophylaxis for recurrent infections. In this review article, we cover the diagnosis, workup, and treatment of children with suspected UTI. We also explore the role of antibiotic prophylaxis, investigational imaging, and approaches to unique populations. Our goal is to help familiarize clinicians with the current management of pediatric UTI as new data becomes implemented in clinical practice.

Pre-verbal children present a diagnostic challenge, as they cannot communicate lower urinary tract signs. The most clinically proven symptom in this age group is fever, but other common symptoms that should raise suspicion include irritability, vomiting, diarrhea, prolonged jaundice, poor feeding, and failure to thrive [14] . Recent advent of UTI risk calculators for febrile infants has improved detection in this cohort. The University of Pittsburgh used their risk calculator to reduce rates of UTI testing (8.1%), increase accuracy of testing, and reduce treatment delays (10.6%) when compared to the AAP algorithm and dipstick urinalysis [63] . At our institution, we have employed a UTI clinical pathway to streamline and simplify diagnosis and treatment (Fig. 1) . The goal of the Connecticut Children's Clinical Pathway program is to standardize best practice, improve patient outcomes, and reduce cost. This is accomplished by decreasing unnecessary variation while promoting safe, effective, and consistent patient care. The pathway for UTI was designed by physicians from the Department of Pediatrics with input from the urology and nephrology divisions. Quality metrics including appropriate use of antibiotics and imaging are tracked. Antibiotic recommendations are routinely reviewed to ensure that they are appropriate based on hospital antibiograms.

Since 5% of children between 2 and 24 months with a fever of unknown origin have a UTI [10] , a urinalysis is an important diagnostic tool. In toilettrained children, the collection method of choice is a mid-stream, clean-catch urine specimen after appropriate genital cleansing. Recent studies have shown a significant rate of urine culture contamination in children who did not perform perineal washings (23.9%) compared to those that did (7.8%) prior to mid-stream urine collection [11, 12] .

In diapered children, three options exist: perineal bag collection, bladder catheterization, and suprapubic aspiration. Up to 85% of bag-collected specimens with a positive culture will be false positives [10] . Bag collection should be treated as an initial screening measure only: a negative result confirms the absence of a UTI [18] . Bladder catheterization is 95% sensitive and 99% specific, and is less technically difficult in comparison to suprapubic aspiration [10] . While some studies claim suprapubic aspiration is more painful and Pediatric Urology (BA VanderBrink and RP Pramod, Section Editors) has a higher rate of collection failure, it has also been shown to have a lower rate of false positives [13] [14] [15] . In our experience, with proper technique and selective use of bedside ultrasound, suprapubic aspiration can be quick and well-tolerated when bladder catheterization is not a good option.

The American Academy of Pediatrics defines a UTI as the presence of at least 50,000 CFU/mL of a single uropathogen obtained by bladder catheterization with a dipstick urinalysis positive for leukocyte esterase (LE) or WBC present on urine microscopy [16] . Due to the high sensitivity of LE, it is commonly used to rule out UTI in its absence. Nitrites have a higher specificity, and are thus used to rule in disease [88] . The presence of bacteria, WBC, and RBC on urine microscopy can add confirmation to the diagnosis. Table 1 shows the sensitivity and specificity of these clinical indicators alone and in combination for diagnosis of UTI.

Culture diagnosis is dependent on collection method, with > 100,000 CFU/ mL required for mid-stream specimen, > 50,000 CFU/mL for catheterization, and > 1000 CFU/mL for suprapubic aspiration [16] . Emerging data has suggested that in infants with fever and pyuria, lowering the colony count for catheterized specimens to 10,000 CFU/mL will accurately diagnose UTI without sacrificing specificity [89] . The most common organism responsible for UTI in children is Escherichia coli, with Klebsiella pneumoniae, Enterococcus faecalis, and Proteus mirabilis also frequently cultured [16, 66, 82] . Table 2 shows a breakdown of common organisms in the community and nosocomial setting.

Cultures are susceptible to contamination from feces and skin flora. Signs of contamination include > 10 squamous epithelial cells/HPF, presence of > 2 bacteria, low bacterial colony count, and growth of non-uropathogens (Lactobacillus, Corynebacterium, Viridans streptococci) [18] . When asymptomatic bacteriuria (AB) is encountered on culture analysis, treatment should be avoided as it can promote symptomatic infections, antibiotic-resistant organisms, and Table 1 The sensitivity and specificity of these clinical indicators alone and in combination for diagnosis of UTI All values include influence from study population demographics *Accuracy found to be highest in patients in urology clinics **Accuracy found to be highest in pregnant women and the elderly AUC , area under the curve-for prediction of positive urine culture for infection Data generated from references [89, 90] side effects. While contamination is common, true AB is an extremely rare event, with prevalence in infant boys and girls found to be < 0.5%, and in boys after infancy, < 0.1% [91] . Higher rates exist in children requiring use of foreign body instrumentation in the GU tract, such as those requiring daily CIC [90] .

Once the clinician has reached a suspected diagnosis of UTI, the child should be treated with antibiotics within the first 48 h to prevent likelihood of renal scarring [6, 7, 25] . There is likely a linear relationship between the prevalence of renal scar formation and delayed time to treatment [7] . Antimicrobial stewardship is more important than ever with the rise of multi-drug-resistant pathogens. This includes extended spectrum beta-lactamase (ESBL) producing organisms, which have been found increasingly in community acquired UTIs [27] [28] [29] . One study found ESBL-producing E. coli composed nearly half of the bacterial strains in their culture-proven cohort [66] . The AAP recommends Bactrim, Augmentin, or cephalosporins (cefixime, cefpodoxime, cephalexin) as first-line agents for uncomplicated pediatric UTI; our institution's clinical pathway recommends Ceftriaxone IV or Cephalexin PO. Unfortunately, there is data suggesting the most common empiric antibiotics (Bactrim, Augmentin, ampicillin, and first-generation cephalosporins) have the highest growth of antibiotic resistance among UTI-producing bacteria [27] [28] [29] . Regardless of the first-line agent typically chosen, clinicians must also review patient-specific culture results and follow local antibiograms and antimicrobial sensitivity patterns available at their institution.

Multiple studies show a 2-to 4-day course of oral antibiotics is just as effective as a 7-to 14-day course in children with cystitis [18, 30, 31] . Those with acute pyelonephritis can also be treated with oral antibiotics for 10-14 days or IV antibiotics for 2-4 days followed by oral therapy [18, 32] .

The purpose of imaging is to identify genitourinary anomalies that increase the risk of recurrent UTI and injury from repeat infections (renal scarring, renal insufficiency). A renal and bladder ultrasound (RBUS) should be obtained in all infants aged 2-24 months after first febrile UTI [18] . Children who are older than 2-24 months who experience recurrent febrile UTIs should also be evaluated, though RBUS has a poor sensitivity for detecting mild-moderate VUR [18] .

Voiding cystourethrogram (VCUG) is indicated if an abnormality is found on RBUS or for recurrent febrile UTI [18] . VCUG is used to identify children with high-grade (IV-V) reflux who are at risk for renal deterioration but should be used selectively given the need for catheterization and the radiation exposure [18] . Multiple studies have found that low-grade VUR does not Pediatric Urology (BA VanderBrink and RP Pramod, Section Editors) increase risk of renal damage and is frequently self-limiting; therefore, the use of VCUG has become increasingly selective. Data has shown less than 40% of children are found to have VUR after their first febrile UTI and among this group, less than 10% have high-grade VUR (IV, V) [16, 61, 62] Contrast-enhanced voiding urosonogram (CEVUS) has emerged as a radiation-free method of evaluating children for VUR. The method works by using contrast-containing echogenic microbubbles that are easily detected using low-mechanical index ultrasound. The diagnostic accuracy of CEVUS for VUR is excellent, with recent studies quoting a sensitivity of 90.4-92% and a specificity of 92.8-98% [20, 21•] . Concordance with VCUG for detection and grading of VUR is 84.3% and 81.8%, respectfully [21•] , with a multitude of data confirming non-inferiority of CEVUS when compared to VCUG [20, 21•, 22-24] .

Dimercaptosuccinate (DMSA) scans can be used to identify patients with renal scarring, however are also sensitive for detecting renal anomalies such as small or absent kidneys, ectopic kidneys, and duplex systems. The AUA recommends DMSA scans when initial RBUS is abnormal or when there is a concern for renal scarring (breakthrough UTIs) [19] . A DMSA scan has a higher sensitivity for detecting renal parenchymal injury when compared to RBUS; however, inflammatory changes to the kidney can cause false-positive scans if performed in the first 4-6 months following an infection [16, 19] . Similar to VCUG, the pitfall of DMSA is radiation exposure, with one study proving the average exposure per scan is 2.84 mSv, equal to 28 chest X-rays per year [60] . DMSA can also be difficult for radiologists to obtain.

Continuous antibiotic prophylaxis (CAP) can be prescribed to prevent renal injury in children who experience recurrent febrile UTIs. Recommendations on prophylaxis can be controversial. Proponents for CAP reference the RIVUR trial, a randomized study that investigated use of CAP in preventing recurrent febrile UTIs in patients with dilated and non-dilated VUR. Bactrim decreased the rate of recurrent UTIs by 50% in all patients with VUR; dilated VUR found the most benefit [33•]. However, the study found no difference in the rate of renal scarring between treatment groups, the outcome of interest to most physicians. This was confirmed by the CUTIE trial, which showed no difference in renal scarring between children with or without VUR who did not receive CAP after febrile UTI [3] . To date, there is no level I data to show CAP has any effect on renal scarring [3, 33•, 44] .

A meta-analysis sought to validate the benefit of CAP in children with VUR and found that with the addition of the RIVUR trial data, statistical significance was achieved [34•]. However, a recent publication using advanced analysis has doubted the statistical power of these results [34•, 35]. Adding to the skepticism is the multitude of publications noting CAP has no significant effect on preventing recurrent UTI in kids with VUR [39- 42, 45, 46] , not to mention that there is a three-fold higher risk of antibiotic-resistant organisms present in infected patients with low-grade VUR on CAP therapy [48] . Given this evidence, the American Urologic Association and our own practice are to recommend continued antibiotic prophylaxis (CAP) for a child < 1 year of age with VUR and a history of febrile urinary tract infection [19] . Prophylaxis should be considered for all patients with high-grade VUR (III-V). CAP is also recommended for children > 1 year of age if they have BBD and VUR [19] . For children with VUR or renal cortical anomalies without BBD, CAP is optional and should be discussed as part of a shared decision-making process.

Bladder and bowel dysfunction is defined by a constellation of lower urinary tract symptoms (LUTS) in conjunction with bowel dysfunction, most notably constipation or encopresis [82, 96, 97] . LUTS include, but are not limited to, dysuria, frequency, incomplete emptying, incontinence, nocturia, and retention. It is thought that the retention of stool in the rectal vault mechanically compresses the bladder, leading to decreased compliance and frequent urination. In addition, there seems to be a neurologic component, with chronic retention of urine and stool leading to a decreased afferent response from the bladder and pelvic floor. This results in an attenuated sensation to urinate and poor relaxation of the pelvic floor during voiding [82, 96, 97] . Children with BBD have increased rates of reflux, UTI, and renal sequelae [96, 97] . Compounding the issue, those with BBD treated medically or surgically for VUR have increased rates of recurrence and poorer outcomes [64, 82] .

About 50% of children with BBD will improve with behavioral intervention alone [98] . Treatment starts with adequate hydration to improve bladder cycling, timed voiding every 2-3 h, appropriate voiding posture, and pelvic floor muscle training (PFMT) with or without biofeedback therapy [82, 96] . In biofeedback, monitors placed on the skin electronically record pelvic floor musculature in real time allowing for improved voluntary control during voiding. Studies have shown a UTI prevention rate of 68-86% in children treated with behavioral therapy and PFMT alone [96, [99] [100] [101] [102] [103] . Medications such as alpha agonists and muscarinic antagonists are pursued if symptoms persist in spite of behavioral treatment and adequate management of constipation for 6 months. If these treatments fail, OnabotulinumtoxinA and sacral neuromodulation are among last resort options [96] .

The initial treatment for constipation in children includes increased fiber intake, proper hydration, and stool softeners. Polyethylene glycol is the most commonly prescribed stool softener in children [96, 98] . Children are often encouraged to sit on the toilet for 10 min after meals to take advantage of the gastrocolic reflex. If these treatments fail to resolve constipation, retrograde enemas, dis-impaction, and anterograde continence enema (ACE) procedures can be employed [96, 98] . There is some data showing the use of Pediatric Urology (BA VanderBrink and RP Pramod, Section Editors) neuromodulation can simultaneously improve overactive bladder and constipation in children with BBD; however, this should be selectively utilized given the invasive nature of the treatment [104, 105] .

The index patient who may benefit from surgery is one who has proven VUR and experiences breakthrough UTIs while receiving CAP therapy [19] . Other reasons include non-compliance with antibiotics or new renal cortical lesions found on surveillance screening [16, 19] .

The most common approaches for ureteral reimplantation are the Politano-Leadbetter, Lich-Gregoir, modified Lich-Gregoir, and Cohen cross-trigonal reimplant. Historically, open surgery remained the gold standard; in recent years, robotic-assisted laparoscopic approaches have good data supporting their efficacy, with lower rates of post-operative pain, less opioid use, shorter hospital stay, and improved cosmesis [50, 51, [53] [54] [55] . Furthermore, there is data proving non-inferiority in VUR downgrading and radiographic resolution when compared to open techniques [50, 52, 54] . In non-experienced centers, robotic-assisted approaches have seen a higher 90-day complication rate and a significantly higher cost to the patient's family [56] .

Endoscopic treatment (ET) involves an injection of a subureteral or intraureteral bulking agent. Dextranomer and hyaluronic acid (Deflux) is the most common anti-reflux agent. There is data showing no difference in prevention of UTI recurrence or renal scarring in patients with VUR undergoing ET when compared to CAP alone [47, 49] . However, endoscopic therapy is still used commonly in clinical practice with the index patient being one with low-grade VUR or an older patient in which reimplantation would be more technically difficult.

It is important to note that children with lower urinary tract dysfunction have an increased surgical failure rate for reflux resolution in both open and endoscopic series. Thus, treating the underlying urinary symptoms should preclude any attempt at surgical intervention for VUR [64] .

The majority of children born with spina bifida (SB) suffer chronically from increased bladder storage pressures, difficulty emptying, and dependency on catheter drainage, which put them at risk for recurrent UTI and renal deterioration [67] . One paper demonstrated 50% of children with spina bifida will experience a UTI by 15 months and 44% will have > 5 UTIs by 15 years old [68] . Based on the National Spina Bifida Patient Registry, > 70% of spina bifida patients perform CIC. This population presents a diagnostic challenge to discern asymptomatic colonization versus symptomatic infection. There is no uniform consensus on symptomatic UTIs in SB patients; however, in a systematic review, fever, positive culture, and Contemporary Management of Urinary Tract Infections in Children P. Olson MD et al. symptoms were the most reported criteria [70] . Symptoms included flank pain, abdominal pain, change in continence patterns, increased urine odor, and dysuria [70, 71] . The primary goal in identifying SB patients with symptomatic UTIs is to prevent renal damage; however, multiple studies have shown that renal function is largely preserved in patients with asymptomatic bacteriuria in the absence of VUR and hostile bladder parameters on urodynamics [69] . Therefore, complete evaluation including urodynamics and ultrasound is key to identify patients at risk for infectious sequelae. Preventing high detrusor pressures, urinary stasis, and constipation will also attenuate risk for infection. While the research does not provide uniform guidelines, patients with fever, culture-positive urine, and new-onset symptoms should be prioritized for antibiotic treatment.

Bladder exstrophy (BE) is a rare condition with an exposed bladder plate, epispadias, and pelvic diastasis [82] . After initial bladder closure, ureteral insertion is commonly at a 90° angle with a very limited intramural tunnel. Thus, a significant number of patients will have VUR and may be at risk of recurrent febrile UTI if ureteral reimplantation is not performed during the operation [81] . Ureteral reimplantation during bladder exstrophy repair has been shown to decrease rates of infection and renal scarring [72, 73, 81] . If reimplantation is not performed primarily, emphasis should be placed in identifying those with VUR and use of prophylactic antibiotics should be considered. Continence remains a challenging issue in this population, with a high rate of CIC dependence or augmentation cystoplasty, both of which are associated with UTI [107] . In addition, those found to have continence after repair tend to have higher rates of VUR and recurrent febrile UTI [81, 108] . One unique option for UTI in patients with urologic reconstructions who already perform CIC is intravesical antibiotic instillation, either as prophylaxis or treatment. In one study that evaluated intravesical gentamycin, serum levels were indetectable and development of antibiotic resistance low (4.16%) [109] . Since patients with BE report high rates of recurrent UTI and renal scarring in adulthood, this population requires close urologic care in childhood and beyond [107] .

Emerging research has identified a relationship between vaginal, intestinal, and urinary bacteria and the development of recurrent UTI. Intestinal bacteria have historically been a focus of research as introital and periurethral colonization with these organisms remains a common etiology for adult female UTIs [74] . In a recent publication, children with recurrent UTIs were found to have higher proportions of fecal bacteria from the Enterobacter family as compared to the Peptostreptococcaceae family found in those without UTI [77] . It is an important distinction, as a 1% relative abundance of Escherichia or Enterococcus species acts as independent risk factor for UTI [75] . In another study, patients with recurrent UTI and Clostridium difficile colitis underwent a fecal transplant, leading to a significant reduction in their UTI Pediatric Urology (BA VanderBrink and RP Pramod, Section Editors) recurrence [76] . While intestinal bacteria can act as a nidus for genitourinary infections, the vaginal flora has a number of mechanisms to protect against bacterial invasion and proliferation. In Stapleton et al.'s randomized phase II trial of adult women, intravaginal instillation of Lactobacillus crispatus led to a significant reduction in recurrent UTIs [78] . Studies on vaginal microbiome transplant have shown preliminary evidence for remission of recurrent bacterial vaginosis, further validating this area as a potential therapeutic target [79] . While research on the pediatric urinary microbiome is still growing, there is data suggesting bacterial dysbiosis in children with recurrent UTI. Kinneman et al. found differences in both the alpha diversity (number of different species at a single site) and the beta diversity (differences in species at multiple sites) in children presenting with UTI when compared to those without UTI [80] , highlighting an investigational difference in bacterial proliferation between these two cohorts.

Clinicians have long sought to prevent renal parenchymal scarring secondary to urinary infection which can lead to hypertension, proteinuria, and chronic renal failure. In recent years, it has been proposed that adjuvant use of corticosteroids in children with pyelonephritis can limit the development of inflammatory cytokines that lead to renal scarring. The data has been mixed, with the largest known clinical trial failing to reach accrual but claiming a non-statistically significant trend towards favorability of adjunctive use of steroids [58] . Smaller investigations have also boasted a significant decrease in DMSA-proven renal scarring [57, 59] . All three studies were underpowered, but two clinical trials are underway (NCT04654507, NCT02034851) which hope to shed more light on this controversial topic.

With the advent of the HPV vaccine in the mid-2000s and now the multitude of vaccines targeting the novel coronavirus, primary prevention has become an intense topic of research, and UTIs are no exception. Scientists from Sequoia Sciences Inc. have recently published a phase I, dose escalation trial of a vaccine targeted against a preserved antigen present in E. coli bacteria [110•] . The vaccine consists of a protein called FimCH adjuvanted with a TLR4 agonist. FimCH is a naturally occurring antigen present on type I pili in E. coli. Type I pili are bacterial appendages that help bacteria bind to oligomannose-containing glycoproteins in human bladders [110• ]. The researchers theorize that patients inoculated with their vaccine will build a IgG-mediated antibody response to FimCH proteins that will penetrate the mucosal surface of the bladder and prevent recurrent infections from occurring. The results of the study proved the vaccine to be extremely well-tolerated, with adverse events limited to mild localized skin reactions, headaches, nausea, and fatigue. All subjects receiving the four-dose vaccination schedule were seropositive after 30 days. The cohort of women with recurrent UTI demonstrated a 150-fold increase in antibodies against FimH proteins [110•] . While this is the first study of a FimH vaccine in humans, prior research has proven its efficacy with a 99% reduction of in vivo E. coli colonization using murine models [111] . A randomized, phase II, placebocontrolled trial has been approved.

Contemporary Management of Urinary Tract Infections in Children P. Olson MD et al.

Pediatric UTI remains a significant source of morbidity in children, especially uncircumcised males in the first year and females throughout life. UTI risk calculators, algorithms, and optimized collection techniques will decrease the rate of false positives and unnecessary antibiotic treatment. Antibiotic-resistant organisms are increasing rapidly; therefore, antibiotic stewardship and use of local antibiograms are more important than ever. Young children with febrile UTI and older children recurrent UTI should undergo investigational imaging. VCUG is invasive and requires radiation; however, newer imaging techniques such as CEVUS provide excellent detection of upper tract disease without the use of radiation. CAP in the setting of VUR is controversial; children with BBD and high-grade VUR derive the most benefit. Patients with complex urologic conditions such as SB and BE require unique approaches to urinary infections. Research into corticosteroids, urinary microbiomes, and UTI vaccinations could change how we treat UTIs and prevent chronic renal insufficiency in high-risk patients.

Philip Olson, Anne G. Dudley, and Courtney K. Rowe declare that they have no conflict of interest.

This article does not contain any studies with human or animal subjects performed by any of the authors.

for children with vesicoureteral reflux. NEJM 370: 2367. A multisite, randomized, placebo-controlled trial published in 2014 that had a significant impact on pediatric medicine. The most important finding being that children with VUR and recurrent UTI's who received antibiotic prophylaxis reduced the risk of recurrence by 50%. Further, the effect on renal scarring was found to be non-significantly different between the placebo and the intervention group. The cohort receiving the most benefit after statistical analysis were those with bladder and bowel dysfunction and high grade VUR. 

particular interest, published recently, have been highlighted as: • Of importance

Newborn circumcision decreases incidence and costs of urinary tract infections during the first year of life

Prevalence of urinary tract infection in childhood: a meta-analysis

Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring

The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections

Prevalence and risk factors for renal scars in children with febrile UTI and/or VUR: a cross-sectional observational study of 565 consecutive patients

Delayed treatment of the first febrile urinary tract infection in early childhood increased the risk of renal scarring

The impact of therapeutic delay time on acute scintigraphic lesion and ultimate scar formation in children with first febrile UTI

Association of Renal Scarring With Number of Febrile Urinary Tract Infections in Children

Identification of children and adolescents at risk for renal scarring after a first urinary tract infection: a meta-analysis with individual patient data

Subcommittee on Urinary Tract Infection: Diagnosis and management of an initial UTI in febrile infants and young children

To clean or not to clean: effect on contamination rates in midstream urine collections in toilet-trained children. Pediatrics

Cleaning the genitalia with plain water improves accuracy of urine dipstick in childhood

Pain in infants who are younger than 2 months during suprapubic aspiration and transurethral bladder catheterization: a randomized, controlled study

A Comparison of Bladder Catheterization and Suprapubic Aspiration Methods for Urine Sample Collection From Infants With a Suspected Urinary Tract Infection

Comparison of pain during two methods of urine collection in preterm infants

Contemporary Management of Urinary Tract Infection in Children

Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children

Reaffirmation of AAP Clinical Practice Guideline: The Diagnosis and Management of the Initial Urinary Tract Infection in Febrile Infants and Young Children 2-24 Months of Age

Management and Screening of Primary Vesicoureteral Reflux in Children

Diagnostic accuracy of contrast-enhanced voiding urosonogram using second-generation contrast with harmonic imaging (CEVUS-HI) study for assessment of vesicoureteral reflux in children: a meta-analysis

Contrast-enhanced voiding urosonography (ceVUS) with the intravesical administration of the ultrasound contrast agent Optison™ for vesicoureteral reflux detection in children: a prospective clinical trial. Pediatr Radiol

Two-dimensional (2D), three-dimensional static (3D) and real-time (4D) contrast enhanced voiding urosonography (ceVUS)

Contemporary Management of Urinary Tract Infections in Children P. Olson MD et al. versus voiding cystourethrography (VCUG) in children with vesicoureteral reflux

Comparison of contrast-enhanced voiding urosonography with voiding cystourethrography in pediatric vesicoureteral reflux

Voiding urosonography with second-generation ultrasound contrast versus micturating cystourethrography in the diagnosis of vesicoureteric reflux

Fever duration during treated urinary tract infections and development of permanent renal lesions

Predictors of Antimicrobial Resistance among Pathogens Causing Urinary Tract Infection in Children

Changes in antimicrobial resistance and demographics of UTIs in pediatric patients in a single institution over a 6-year period

Changing prevalence and antibiotic drug resistance pattern of pathogens seen in community-acquired pediatric urinary tract infections at a tertiary care hospital of North India

Antibacterial resistance patterns of pediatric community-acquired urinary infection: Overview

Short-course versus conventional length antimicrobial therapy for uncomplicated lower urinary tract infections in children: a meta-analysis of 1279 patients

Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children

CD003 772. pub4. pyelonephritis and renal scars? A randomized, controlled trial

Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial

Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study

Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study

A Reanalysis of the RIVUR Trial Using a Risk Classification System

Efficacy of antibiotic prophylaxis in children with vesicoureteral reflux: systematic review and meta-analysis

Interventions for primary vesicoureteric reflux

Long-term antibiotics for preventing recurrent urinary tract infection in children

Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomised controlled trials

Interventions for primary vesicoureteric reflux

The Swedish infant high-grade reflux trial: UTI and renal damage

Prospective multicenter study on robotassisted laparoscopic extravesical ureteral reimplantation (RALUR-EV): Outcomes and complications

Outcomes of complex robot-assisted extravesical ureteral reimplantation in the pediatric population

Robot-assisted laparoscopic ureteral reimplantation: a single surgeon comparison to open surgery

Objective pain assessment after ureteral reimplantation: comparison of open versus robotic approach

Pediatric robotic extravesical ureteral reimplantation: comparison with open surgery

Robot-assisted laparoscopic versus open ureteral reimplantation for pediatric vesicoureteral reflux: a systematic review and meta-analysis

Robotic versus open pediatric ureteral reimplantation: Costs and complications from a nationwide sample

Adjunctive oral methylprednisolone in pediatric acute pyelonephritis alleviates renal scarring

Corticosteroids to prevent kidney scarring in children with a febrile urinary tract infection: a randomized trial

Oral steroids for reducing kidney scarring in young children with febrile urinary tract infections: the contribution of Bayesian analysis to a randomized trial not reaching its intended sample size

Contemporary Management of Urinary Tract Infections in Children P

Cost and radiation exposure in the workup of febrile pediatric urinary tract infections

Imaging studies after a first febrile urinary tract infection in young children

Incidence of abnormal imaging and recurrent pyelonephritis after first febrile urinary tract infection in children 2 to 24 months old

Development and Validation of a Calculator for Estimating the Probability of Urinary Tract Infection in Young Febrile Children

Functional disorders of the lower urinary tract in children

Urinary tract infections in children: an overview of diagnosis and management

Causative pathogens and antibiotic resistance in children hospitalized for urinary tract infection

Prevention of chronic kidney disease in spina bifida

Relationship of asymptomatic bacteriuria and renal scarring in children with neuropathic bladders who are practicing clean intermittent catheterization

Variation in definitions of urinary tract infections in spina bifida patients: a systematic review

Bacteriuria management and urological evaluation of patients with spina bifida and neurogenic bladder: a multicenter survey

Bilateral ureteral reimplantation at primary bladder exstrophy closure

The management of bladder exstrophy: the manchester experience

Recurrent UTIs in Girls: What Is the Role of the Microbiome?

Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection

Fecal microbiota transplantation for recurrent clostridium difficile infection reduces recurrent urinary tract infection frequency

Intestinal microbiome as a risk factor for urinary tract infections in children

Randomized, placebo-controlled phase 2 trial of a lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection

Vaginal microbiome transplantation in women with intractable bacterial vaginosis

Assessment of the urinary microbiome in children younger than 48 months

Impact of bilateral ureteral reimplantation at the time of complete primary repair of bladder exstrophy on reflux rates, renogram abnormalities and bladder capacity

Handbook of Pediatric Urology

Unique epidemiology of nosocomial urinary tract infection in children

Community-acquired enterococcal urinary tract infections in hospitalized children

Candiduria in children and susceptibility patterns

Section Editors) of recovered Candida species to antifungal drugs in Ahvaz

The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy

Performance of the dipstick screening test as a predictor of negative urine culture

Reevaluating the true diagnostic accuracy of dipstick tests to diagnose urinary tract infection using Bayesian latent class analysis

Accuracy of the urinalysis for urinary tract infections in febrile infants 60 days and younger

Lack of morbidity from urodynamic studies in children with asymptomatic bacteriuria

Prevalence of Asymptomatic Bacteriuria in Children: A Meta-Analysis

Evaluation of the Diagnostic Value of Contrast-Enhanced Voiding Urosonography with Regard to the Further Therapy Regime and Patient Outcome-A Single-Center Experience in an Interdisciplinary Uroradiological Setting

Residual intravesical iodinated contrast: a potential cause of false-negative reflux study at contrast-enhanced voiding urosonography

Delayed exstrophy repair (DER) does not compromise initial bladder development

Delayed primary repair of bladder exstrophy: ultimate effect on growth

Bladder and bowel dysfunction in children: An update on the diagnosis and treatment of a common, but underdiagnosed pediatric problem

Functional constipation in children

Bladder control training in girls with lower urinary tract dysfunction

Diaphragmatic breathing exercises and pelvic floor retraining in children with dysfunctional voiding

Animated biofeedback: An ideal treatment for children with dysfunctional elimination syndrome

Correlation between uroflowmetry parameters and treatment outcome in children with dysfunctional voiding

Voiding dysfunction in children. Pelvic-floor exercises or biofeedback therapy: A randomized study

Electrical nerve stimulation for overactive bladder in children

Evaluation of constipation after parasacral transcutaneous electrical nerve stimulation in children with lower urinary tract dysfunction-a pilot study

Pelvic floor biofeedback therapy in children: Assessment of symptom scores in responders and non-responders

Bladder exstrophy: We need to improve A lot

Long-Term fate of the upper urinary tract and ITS association with continence in exstrophy patients

Intravesical gentamicin instillation for the treatment and prevention of urinary tract infections in complex paediatric urology patients: evidence for safety and efficacy

Contemporary Management of Urinary Tract Infections in Children P

A first of its kind Phase I, dose escalation trial investigating the use of a vaccine against FimH protein present on gram negative bacteria responsible for recurrent UTI's. The results showed that the vaccine was well-tolerated among all participants and induction of binding and functional antibodies was successful

Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination